Purpose of the Procedure
- Differentiate between benign and malignant nodules with high precision
- Avoid unnecessary diagnostic or exploratory surgeries
- Identify specific genetic mutations associated with thyroid cancer
Achieve precise diagnostic clarity for thyroid nodules using advanced genomic testing. This procedure helps differentiate benign from malignant nodules, potentially preventing unnecessary surgeries and guiding your personalized treatment plan effectively.
Scientific name: Molecular Testing for Thyroid Nodules (Genomic Expression)
Advanced molecular analysis of thyroid FNA samples evaluating genetic mutations and expression. It distinguishes between benign and malignant nodules, providing crucial diagnostic insights to guide surgical or monitoring decisions.